FDA Adverse Event Malfunction Summary report: N

FLEXTEND

MDR report key: 3041061 · Received April 8, 2013

Report

Report Number
2124215-2013-01409
Event Type
Malfunction
Date Received
April 8, 2013
Date of Event
January 11, 2013
Report Date
January 11, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE RA LEAD REMAINS IN SERVICE FOR SENSING. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT IMPLANTED WITH THIS RIGHT ATRIAL (RA) LEAD WAS SEEN IN THE CLINIC FOR A ROUTINE FOLLOW-UP. A BOSTON SCIENTIFIC FIELD REPRESENTATIVE REVIEWED THE PATIENT'S CHART AND FOUND A NOTE STATING THAT THIS LEAD HAD DISLODGED ONE DAY POST-IMPLANT. NO SENSING OR CAPTURE WAS OBSERVED. THE DEVICE WAS REPROGRAMMED TO VVI PACING MODE, AND THE PATIENT WAS SEEN THREE DAYS LATER FOR EVALUATION. THE ATRIAL LEAD WAS SENSING APPROPRIATELY, WITH NO CAPTURE. THE DEVICE WAS THEN REPROGRAMMED TO VDD PACING MODE. NO ADVERSE PATIENT EFFECTS OCCURRED DUE TO THE ATRIAL LEAD DISLODGEMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
142874 FLEXTEND IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4087

Patients

Seq Age Sex Outcome Treatment
1